LAM Therapeutics Closes $40M in Financing and Announces Two Clinical-Stage Programs in Rare Diseases and Cancer

Corporate Breaking News

Home : LAM Therapeutics Closes $40M in Financing and Announces Two Clinical-Stage Programs in Rare Diseases and Cancer

Feb 04 2016	LAM Therapeutics Closes $40M in Financing and Announces Two Clinical-Stage Programs in Rare Diseases and Cancer
Bringing the Total Raised for the Current Class of 4Catalyzer Companies to a Quarter-Billion Dollars


Source:http://www.marketwired.com/mw/release.do?id=2093486&sourceType=3

Related News
» Foodee Raises $6 Million CAD Series A to Expand On-Demand Corporate Catering in the US » Trump Goes on Anti-Cruz Tirade With 'Dirty' Campaign Charge